Khuhawar M Y, Rind F M A
Institute of Chemistry, University of Sindh, Jamshoro, Pakistan.
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jan 25;766(2):357-63. doi: 10.1016/s0378-4347(01)00510-2.
Isoniazid (IN), pyrazinamide (Pz) and rifampicin (Rf) are separated on YMC-ODS column. IN was derivatized with 2-fluorene-carboxaldehyde (FA). The separation was achieved using ethanol-chloroform-acetonitrile water by isocratic elution and detected at 337 nm. The detection limits were 0.11 ng, 0.2 ng and 13 ng/injection (5 microl) for IN, Pz and Rf, respectively. The method of analysis was applied to the pharmaceutical preparations and in the blood samples of the patients suffering from tuberculosis after undergoing chemotherapy with IN, Pz and Rf. The amounts quantitated in blood showed 0.97 to 1.58 microg/ml IN, 3.44 to 4.09 microg/ml Pz and 1.98 to 3.5 microg/ml Rf with coefficient of variations 0.8-1.8%, 0.9-1.3% and 0.8-2.1%, respectively.
异烟肼(IN)、吡嗪酰胺(Pz)和利福平(Rf)在YMC-ODS柱上分离。IN用2-芴甲醛(FA)衍生化。采用乙醇-氯仿-乙腈-水等度洗脱实现分离,并在337nm处检测。IN、Pz和Rf的检测限分别为0.11ng、0.2ng和13ng/进样(5微升)。该分析方法应用于药物制剂以及接受IN、Pz和Rf化疗的肺结核患者的血样。血样中定量的含量显示IN为0.97至1.58微克/毫升,Pz为3.44至4.09微克/毫升,Rf为1.98至3.5微克/毫升,变异系数分别为0.8 - 1.8%、0.9 - 1.3%和0.8 - 2.1%。